fbpx
New Alzheimer’s disease drug met with more scrutiny than optimism

New Alzheimer’s disease drug met with more scrutiny than optimism

The Food and Drug Administration has approved the first new treatment for Alzheimer’s disease in 18 years, a drug called aducanumab, sold under the brand name Aduhelm. The president and CEO of the Alzheimer’s Association, Harry Johns, declared this new drug a victory...

Get 20% Off Training Packages in the Month of November

Day(s)

:

Hour(s)

:

Minute(s)

:

Second(s)

Website Development